Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2008, p. 1655-1658, Vol. 46, No. 5
0095-1137/08/$08.00+0 doi:10.1128/JCM.02047-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Focus Diagnostics, Cypress, California
Received 19 October 2007/ Returned for modification 13 December 2007/ Accepted 10 March 2008
|
|
|---|
|
|
|---|
Swab tips, which are typically rayon or Dacron, should be prepared with material that collects sufficient specimen material, is nontoxic to microorganisms, maintains viability in conjunction with the transport medium, and releases specimen material efficiently onto agar media. A new nylon-tipped swab (ESwab; Copan Diagnostics, Inc., Corona, CA) prepared by spray-on flocked fiber technology has been developed for transport of bacteria and viruses. This technology provides stronger capillary action and strong hydraulic uptake of liquids, which should result in better specimen collection. This design should also provide more efficient release of specimen material and, therefore, less entrapment of specimen than occurs with typical rayon or Dacron fiber-tipped swabs. The ESwab shaft is scored for ease and consistency of tip breakage into the modified liquid Amies transport medium. A swab capture mechanism in the cap locks the broken swab shaft into the cap when it is fully closed.
In this study, we evaluated the new ESwab with liquid Amies transport medium for maintenance of viability of aerobic and anaerobic bacteria according to the CLSI M40-A quantitative elution method (2). The Becton Dickinson CultureSwab MaxV swab and Remel BactiSwab (RBS; Remel, Lenexa, KS), both with Amies agar gel, were tested as comparators.
(This work was presented in part at the 106th General Meeting of the American Society for Microbiology, Orlando, FL [9a].)
|
|
|---|
Quantitative elution. Tests were performed by the CLSI M40-A quantitative elution method (2). An organism suspension from a freshly grown isolate of each strain was prepared in sterile saline to a turbidity equivalent to that of a 0.5 McFarland standard. The suspension was further diluted 1:10 in sterile saline to achieve an inoculum concentration of approximately 1.5 x 107 CFU/ml. For growth controls, serial 10-fold dilutions were prepared from the suspension and plated on duplicate plates of the appropriate medium. The plates were then incubated at 37°C in the appropriate atmosphere, and colony counts were obtained to confirm that the inoculum concentration was acceptable (107 to 109 CFU/ml).
For swab testing, 12 100-µl aliquots of the 107-CFU/ml inoculum of each organism suspension were placed onto the surface of a sterile Petri plate. Each of 12 swabs from one manufacturer was rolled into 1 of the 12 100-µl inoculum spots for 15 s to ensure complete absorption. Triplicate swabs of each type were inoculated for each storage time period (0, 6, 24, or 48 h), for a total of 12 swabs of each manufacturer's swab type inoculated for each storage temperature to be tested. All swabs were immediately placed into their respective transport systems and stored at a controlled 23 ± 1°C for room temperature storage or 4°C for refrigerated storage for each time period prior to plate inoculation.
After the appropriate storage time, including 0 h (tested within 15 min of inoculation), each of the Amies agar gel swabs (MaxV and RBS) was removed from the transport medium, placed into 0.9 ml sterile saline, and mixed by vortexing for 15 s. The ESwab was mixed in the transport tube by being vortexed for 15 s, and 100 µl of the liquid Amies medium was transferred to 0.9 ml of sterile saline. Serial 10-fold dilutions of each swab system suspension were prepared to obtain suspensions theoretically equivalent to 106 to 101 CFU/ml. The ESwab transport tube was considered the 106-CFU/ml tube because of the initial 1:10 dilution into the liquid Amies medium. A 100-µl aliquot of each dilution was removed, placed onto the surface of duplicate agar media appropriate for the organism tested, and inoculated over the entire agar surface with a sterile spreader. All plates were incubated at 37°C under appropriate atmospheric conditions for the organism tested. Incubation of the plates was done for up to 48 h for aerobic organisms and up to 96 h for anaerobic organisms. After incubation, two readers counted colonies on plates with 30 to 300 countable colonies, and the average colony count was used. The average CFU at storage times of 6, 24, and 48 h were compared to the average CFU at 0 h. CLSI M40-A (2) criteria were used for evaluation, as follows: a swab system was considered acceptable for the organism tested if the change in CFU from the 0-h value declined no more than 3 log10 (1 x 103 CFU ± 10%) for storage at room temperatures and, for storage at refrigerated temperature, no more than a 1-log increase or no more than a 3-log10 (1 x 103 CFU ± 10%) decline compared to the 0-h CFU. CLSI has established a storage evaluation time of 24 h for N. gonorrhoeae and 48 h for all other organisms. There is no CLSI M40-A interpretation for N. gonorrhoeae beyond a 24-h storage time. Similarly, no CLSI standard exists for evaluation of overgrowth in swab transport systems stored at room temperature. Comparison of the swab transport systems was based on average CFU and percent recovery of viable organisms at each incubation time and at each storage temperature.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Recovery of aerobic microorganisms from three swab systems stored at room temperature
|
|
View this table: [in a new window] |
TABLE 2. Recovery of aerobic microorganisms from three swab systems stored at refrigerated temperature
|
|
View this table: [in a new window] |
TABLE 3. Recovery of anaerobic microorganisms from three swab systems stored at room temperature
|
|
View this table: [in a new window] |
TABLE 4. Recovery of anaerobic microorganisms from three swab systems stored at refrigerated temperature
|
|
|
|---|
The ESwab met CLSI acceptance criteria at both storage temperatures for all isolates tested except for P. melaninogenica. In fact, none of the three swab transport systems maintained P. melaninogenica viability after 24 h or 48 h of room temperature storage, possibly because inoculation preparation procedures were performed under aerobic conditions. However, this explanation does not fully account for the unacceptable results in that the same preparation procedures were used for the refrigerated storage studies, which recovered P. melaninogenica isolates with all three swab transport systems (the RBS gave an unacceptable CFU/ml). Others have also reported difficulty in recovering P. melaninogenica from swab transport systems stored at room temperature (5, 6). We are not aware of any published swab studies of P. melaninogenica tested at refrigerated storage temperatures.
Overgrowth of an organism in a swab transport system is problematic and would misrepresent the true relative proportions of a mixed infection, therefore yielding misleading culture results. However, there are no CLSI standards for organism overgrowth at room temperature incubation (2). We observed heavy overgrowth (>105% increase) of P. aeruginosa after room temperature storage for the ESwab and the MaxV systems, and the RBS also showed lesser overgrowth. Overgrowth of P. aeruginosa has been reported for other swab systems after storage at room temperature (6, 7, 8, 9) and for enterics (1, 8). The ESwab allowed less, but distinct, growth of S. pyogenes during room temperature storage (>10-fold recovery at 24 and 48 h). Growth of S. pyogenes in swab systems has been observed previously (7, 8). In the present study, the MaxV swab also yielded S. pyogenes growth of >100-fold. However, this amount of growth would still be within acceptable CLSI limits (2) if refrigerated storage limits were applied. The increase in numbers of the B. fragilis isolate with the ESwab system after 24 h of room temperature storage remains unexplained, but this could have been due to initial growth in the ESwab system followed by a decline due to loss of viable cells at 48 h. No swab showed overgrowth at refrigerated temperatures, consistent with previous studies of other swab systems (3, 6, 7).
Overall, the ESwab performed as well as the MaxV and RBS systems for maintenance of aerobic organism viability at refrigerated temperature storage. At room temperature, the ESwab maintained organism viability as well as the MaxV swab and better than the RBS, which failed to recover H. influenzae. The ESwab maintained anaerobic organism viability equivalent to that with the MaxV swab at both room and refrigerated temperatures and was considered better than the RBS, which failed to recover P. anaerobius at both storage temperatures. No swab system recovered P. melaninogenica after 24 h of room temperature storage. The RBS also yielded unacceptable recovery of P. melaninogenica after 48 h of refrigerated temperature storage. Only one lot of each swab type was used, and this may have accounted for the failures with the RBS. Further studies that test multiple lots of each swab type might need to be performed to help determine if lot-to-lot variations exist with regard to this type of evaluation.
In conclusion, the ESwab system is an acceptable swab transport system for both aerobes and anaerobes. This system met CLSI acceptance criteria for all aerobic and anaerobic isolates when it was tested under refrigerated storage conditions and failed to allow growth of only P. melaninogenica when it was tested at room temperature (as did both comparator swabs). For the laboratory, caution might be advised in using swab transport devices that are not specifically designed for transport of specimens for anaerobic culture, since our study indicates that very fastidious anaerobes might be missed after longer storage and transport (>6 h), especially if they are maintained under room temperature conditions.
We gratefully acknowledge the assistance of Jose Matud (Focus Diagnostics, Inc.) and Jeff Radcliff (Quest Diagnostics Nichols Institute, San Juan Capistrano, CA) with preparation of the manuscript.
Published ahead of print on 19 March 2008. ![]()
Present address: Agensys, 1545 17th Street, Santa Monica, CA 90404. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»